BCDA.NASDAQBiocardia, INC

Form 4: BioCardia Executive Edward Gillis Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Senior Vice President of Devices at BioCardia, Edward Gillis, reports acquisition and disposal of common stock related to vested restricted stock units.

Summary

  • On October 11, 2024, Edward Gillis, Senior Vice President of Devices at BioCardia, Inc., reported transactions involving the company's common stock.
  • Gillis acquired 15,808 shares of common stock at $2.65 per share through the vesting of restricted stock units (RSUs).
  • Simultaneously, 6,840 shares were withheld by BioCardia to cover income tax obligations related to the RSU settlement at $2.65 per share.
  • Following these transactions, Gillis directly owns 12,225 shares of BioCardia common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions related to executive compensation. The acquisition of shares through RSU vesting is generally a positive sign, but the simultaneous withholding for taxes is a standard procedure.

Positives

  • The vesting of RSUs indicates that Gillis has met certain performance or time-based criteria, aligning his interests with the company's success.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, allowing investors to monitor potential alignment of interests between management and shareholders.

Comparison to Industry Standards

  • Form 4 filings are a standard regulatory requirement for publicly traded companies in the United States, ensuring transparency in insider trading activities.
  • Similar filings are made by executives at comparable companies like Cytokinetics and CRISPR Therapeutics, providing investors with insights into management's perspective on their respective companies' stock.

Stakeholder Impact

  • The transactions have a minor impact on shareholders by slightly increasing the number of shares outstanding.

Key Dates

DateDescription
10/11/2024Date of stock transactions (acquisition and disposal related to RSU vesting).
10/16/2024Date of signature on the Form 4 filing.

Keywords

BioCardia, BCDA, Edward Gillis, Form 4, Stock Transaction, Restricted Stock Units, RSU, Beneficial Ownership, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.